Research Interests
Integration of active machine learning, biomedical data science, and biochemical experiments for the analysis and design of personalized therapeutic opportunities.
Selected Grants
Pharmacological Sciences Training Program
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2025 - 2030Designing Personalized Formulations with Machine Learning
ResearchPrincipal Investigator · Awarded by National Institute of General Medical Sciences · 2023 - 2028University Training Program in Biomolecular and Tissue Engineering
Inst. Training Prgm or CMEMentor · Awarded by National Institute of General Medical Sciences · 1994 - 2027Computational Design of Antibody-Drug-Excipient Nanoparticles
ResearchPrincipal Investigator · Awarded by National Institute of Biomedical Imaging and Bioengineering · 2023 - 2026Predicting the effects of microbial metabolites on NOD¿like receptors
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2021 - 2022Identifying the molecular mediators of microbiome-host interactions through machine learning
ResearchPrincipal Investigator · Awarded by North Carolina Biotechnology Center · 2021 - 2022External Relationships
- AbbVie, Inc.
- Areteia Therapeutics
- F1000 Research, Chemical Information Gateway
- Frontiers In Drug Discovery
- Guidepoint Global
- JSR Corporation
- Start2
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.